In Vitro Activities of Linezolid against Multiple Nocardia Species
AUTOR(ES)
Brown-Elliott, Barbara A.
FONTE
American Society for Microbiology
RESUMO
Linezolid was tested by broth microdilution against 140 clinical Nocardia isolates belonging to seven species. The MIC at which 50% of the strains are inhibited (MIC50) and MIC90 for all species other than Nocardia farcinica were 2 and 4 μg/ml. Linezolid is the first antimicrobial agent demonstrated to be active against all Nocardia species.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=90460Documentos Relacionados
- In Vitro Activities of New Antimicrobials against Nocardia brasiliensis
- In Vitro Activity of PNU-100766 (Linezolid), a New Oxazolidinone Antimicrobial, against Nocardia brasiliensis
- In Vitro and In Vivo Activities of Antimicrobials against Nocardia brasiliensis
- In Vitro Activities of Linezolid against Important Gram-Positive Bacterial Pathogens Including Vancomycin-Resistant Enterococci
- Activities of Linezolid against Rapidly Growing Mycobacteria